About iwAL

logologo

About the Meeting

iwAL is an annual workshop led by scientific leaders in AML and ALL, which will bring together top clinical and translational research minds to discuss the latest advances. 

In collaboration with relevant stakeholders, the aim is to identify key clinical and translational research priorities to help improve clinical care of acute leukemias. 

In keeping with the ethos of iwAL, the emphasis of the workshop will be on short, high-level presentations, complemented by sessions of interactive debate and panel discussions. 

2025 Meeting

19-21 Sep

Washington D.C., DC, USA

Workshop Objectives 

  • To create an annual opportunity for scientific exchange of ideas, knowledge, and research in acute leukemias 
  • To enhance networking and inter-disciplinary collaborations internationally 
  • To create a platform for a united voice from the acute leukemia scientific/research community to provide focused input into the research priorities and future trial design 
about
circle strips

Meeting Organizer

Meeting Organizer 

Magdalen Medical Publishing (MMP) is an agile and fast-growing digital publisher of independent, open-access medical news and education for the online healthcare professional community via their online video journals. 

In addition to online publishing, MMP also develops and organizes high-level scientific meetings and workshops that promote scientific exchange such as this meeting, by bringing together leading international clinical and translational research minds. 

For more information, please visit www.medicalpublishing.co.uk  

Media Partner

The Video Journal of Hematology and Hematological Oncology (VJHemOnc) is an global, open-access video journal, dedicated to providing trusted and up-to-date independent medical education to improve the awareness of advances in the management of hematological cancers and share best practice within the hematology community. 

The goal of the journal is to expedite learning through the sharing of new data and expert opinion, and to rapidly disseminate the latest news and information to healthcare professionals worldwide, in a range of innovative digital media – including video and blog formats. 

VJHemOnc content is led by editorial boards of highly-respected thought leaders with a combined expertise that spans the spectrum of hematology and hematological cancers. All content is created and published under the guidance of this board of world-leading experts. 

For more information, please visit www.VJHemOnc.com